These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23563661)

  • 1. Ceramide in cystic fibrosis.
    Grassmé H; Riethmüller J; Gulbins E
    Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids in cystic fibrosis.
    Becker KA; Henry B; Ziobro R; Riethmüller J; Gulbins E
    Expert Rev Respir Med; 2011 Aug; 5(4):527-35. PubMed ID: 21859272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
    Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
    Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
    Becker KA; Tümmler B; Gulbins E; Grassmé H
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
    Becker KA; Grassmé H; Zhang Y; Gulbins E
    Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
    Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide and sphingosine in pulmonary infections.
    Seitz AP; Grassmé H; Edwards MJ; Pewzner-Jung Y; Gulbins E
    Biol Chem; 2015 Jun; 396(6-7):611-20. PubMed ID: 25720061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease.
    Brodlie M; McKean MC; Johnson GE; Gray J; Fisher AJ; Corris PA; Lordan JL; Ward C
    Am J Respir Crit Care Med; 2010 Aug; 182(3):369-75. PubMed ID: 20395562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.
    Caretti A; Vasso M; Bonezzi FT; Gallina A; Trinchera M; Rossi A; Adami R; Casas J; Falleni M; Tosi D; Bragonzi A; Ghidoni R; Gelfi C; Signorelli P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):775-790. PubMed ID: 28439630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide in bacterial infections and cystic fibrosis.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Biol Chem; 2008 Nov; 389(11):1371-9. PubMed ID: 18783339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the inflammasome by ceramide in cystic fibrosis lungs.
    Grassmé H; Carpinteiro A; Edwards MJ; Gulbins E; Becker KA
    Cell Physiol Biochem; 2014; 34(1):45-55. PubMed ID: 24977480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD95 in pulmonary inflammation and infection in cystic fibrosis.
    Becker KA; Henry B; Ziobro R; Tümmler B; Gulbins E; Grassmé H
    J Mol Med (Berl); 2012 Sep; 90(9):1011-23. PubMed ID: 22314624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.
    Saint-Criq V; Ruffin M; Rebeyrol C; Guillot L; Jacquot J; Clement A; Tabary O
    Eur J Pharmacol; 2012 Jan; 674(1):1-6. PubMed ID: 22056837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Zhang Y; Gulbins E
    Open Respir Med J; 2010 Mar; 4():39-47. PubMed ID: 20556203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis.
    Venkatakrishnan V; Packer NH; Thaysen-Andersen M
    Expert Rev Respir Med; 2013 Oct; 7(5):553-76. PubMed ID: 24138697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and novel possibilities of diagnosis of cystic fibrosis].
    Kilian K; Kisiel BM
    Pol Merkur Lekarski; 2006 May; 20(119):582-5. PubMed ID: 16875168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.